With 0.75 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.8 million shares. During the session, the Pharmaceutical Retailers company that operates in wider Healthcare sector, reached to the highest price of $3.43 whereas the lowest price it dropped to was $3.27. The 52-week range on HITI shows that it touched its highest point at $3.62 and its lowest point at $1.57 during that stretch. Beta for the stock currently stands at 0.84.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HITI was up-trending over the past week, with a rise of 5.90%, but this was down by -3.40% over a month. Three-month performance surged to 55.00% while six-month performance rose 66.34%. The stock gained 99.42% in the past year, while it has gained 10.36% so far this year.
Float and Shares Shorts:
At present, 80.45 million HITI shares are outstanding with a float of 73.39 million shares on hand for trading. On 2024-12-13, short shares totaled 4.05 million, which was 502.00000000000006 higher than short shares on 1731628800. In addition to Mr. Harkirat Grover as the firm’s Founder, CEO, President & Executive Chairman, Mr. Aman Sood serves as its Chief Operating Officer.
Institutional Ownership:
Through their ownership of 0.07636 of HITI’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-07-31, HITI reported revenue of $131685000.0 and operating income of $4486000.0. The EBITDA in the recently reported quarter was $10170000.0 and diluted EPS was $0.01.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HITI since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HITI analysts setting a high price target of 4.5 and a low target of 4.5, the average target price over the next 12 months is 4.5. Based on these targets, HITI could surge 31.96% to reach the target high and rise by 31.96% to reach the target low. Reaching the average price target will result in a growth of 31.96% from current levels.
Analysts have provided yearly estimates in a range of $0.00599172 being high and -$0.00199724 being low. For HITI, this leads to a yearly average estimate of $0.00199724.
